Testing effectiveness (Phase 2)Not Yet RecruitingNCT07247201
What this trial is testing
Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients
Who this might be right for
Nasopharyngeal Carcinoma (NPC)Minimal Residual DiseaseRecurrent Nasopharyngeal Carcinoma+1 more
Singapore General Hospital 31